SCHEMBL6465795

SCHEMBL6465795

NC(=O)NCc1[c]cccc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
RECQL P46063 1/20 0.41
BCAT2 O15382 1/20 0.40
MTNR1A P48039 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
GAA P10253 4/20 0.32
MAPT P10636 1/20 0.32
GFER P55789 1/20 0.32
ALDH1A1 P00352 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16935654 0.82 AOC3 (0.46) CYP2C9CYP2C19MEN1KMT2ACYP1A2
SCHEMBL754247 0.81 NPSR1 (0.46) POLBMTNR1AKMT2AMAPTALDH1A1
SCHEMBL8643018 0.81 F2 (0.30)
SCHEMBL10443522 0.81 ALDH1A1 (0.35) POLBMEN1KMT2ATSHRGAA
SCHEMBL5607767 0.79 GAA (0.53) POLBMEN1KMT2AGAAALDH1A1
SCHEMBL11547647 0.79 TSHR (0.42) CYP2C9CYP2C19CYP2D6TSHRALDH1A1
SCHEMBL16935642 0.78 RIPK1 (0.40) POLBKMT2AMAPTRAB9A
SCHEMBL5032139 0.76 ALDH1A1 (0.40) POLBRECQLMEN1KMT2AGAA
SCHEMBL18227116 0.76 KMT2A (0.36) KMT2AALDH1A1
SCHEMBL2209032 0.75 CA2 (0.38) POLBCYP2C19RECQLMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1408963-A1 2- 5-(5-CARBAMIMIDOYL-1 i H /i -HETEROARYL)-6-HYDROXYBIPHENYL-3-YL]-SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-04-21 EP claimed
WO-2003006011-A1 2-[5-(5-CARBAMIMIDOYL-1H-HETEROARYL)-6-HYDROXYBIPHENYL-3-YL]-SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2003-01-23 WO claimed
EP-1569912-A2 2-(2-HYDROXYBIPHENYL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-09-07 EP disclosed
WO-2004050637-A2 2-(2-HYDROXYBIPHENYL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-06-17 WO disclosed
EP-0885186-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1998-12-23 EP disclosed
WO-1997019911-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1997-06-05 WO disclosed